172 related articles for article (PubMed ID: 6254456)
1. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
Orr LE; McKernan JF; Bloome B
Arch Intern Med; 1980 Nov; 140(11):1431-3. PubMed ID: 6254456
[TBL] [Abstract][Full Text] [Related]
2. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
Orr LE; McKernan JF
J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
[TBL] [Abstract][Full Text] [Related]
3. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.
Frytak S; Moertel CG; O'Fallon JR; Rubin J; Creagan ET; O'Connell MJ; Schutt AJ; Schwartau NW
Ann Intern Med; 1979 Dec; 91(6):825-30. PubMed ID: 517882
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Gilbert CJ; Ohly KV; Rosner G; Peters WP
Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
[TBL] [Abstract][Full Text] [Related]
5. Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
Lane M; Vogel CL; Ferguson J; Krasnow S; Saiers JL; Hamm J; Salva K; Wiernik PH; Holroyde CP; Hammill S
J Pain Symptom Manage; 1991 Aug; 6(6):352-9. PubMed ID: 1652611
[TBL] [Abstract][Full Text] [Related]
6. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
Lane M; Smith FE; Sullivan RA; Plasse TF
Am J Clin Oncol; 1990 Dec; 13(6):480-4. PubMed ID: 2173391
[TBL] [Abstract][Full Text] [Related]
7. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
Ekert H; Waters KD; Jurk IH; Mobilia J; Loughnan P
Med J Aust; 1979 Dec; 2(12):657-9. PubMed ID: 231736
[TBL] [Abstract][Full Text] [Related]
9. Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.
Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Simon RM; Rosenberg SA
Ann Intern Med; 1979 Dec; 91(6):819-24. PubMed ID: 293141
[TBL] [Abstract][Full Text] [Related]
10. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.
McCabe M; Smith FP; Macdonald JS; Woolley PV; Goldberg D; Schein PS
Invest New Drugs; 1988 Sep; 6(3):243-6. PubMed ID: 2847994
[TBL] [Abstract][Full Text] [Related]
13. A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Rosenberg SA
Cancer; 1981 Apr; 47(7):1746-51. PubMed ID: 6261926
[TBL] [Abstract][Full Text] [Related]
14. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
Einhorn LH; Nagy C; Furnas B; Williams SD
J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
[TBL] [Abstract][Full Text] [Related]
15. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
Sallan SE; Cronin C; Zelen M; Zinberg NE
N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702
[TBL] [Abstract][Full Text] [Related]
16. Oral granisetron for the prevention of acute late onset nausea and vomiting in patients treated with moderately emetogenic chemotherapy.
Friedman CJ; Burris HA; Yocom K; Blackburn LM; Gruben D
Oncologist; 2000; 5(2):136-43. PubMed ID: 10794804
[TBL] [Abstract][Full Text] [Related]
17. A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
Niiranen A; Mattson K
Am J Clin Oncol; 1985 Aug; 8(4):336-40. PubMed ID: 3002167
[TBL] [Abstract][Full Text] [Related]
18. THC or Compazine for the cancer chemotherapy patient--the UCLA study. Part II: Patient drug preference.
Ungerleider JT; Sarna G; Fairbanks LA; Goodnight J; Andrysiak T; Jamison K
Am J Clin Oncol; 1985 Apr; 8(2):142-7. PubMed ID: 3010696
[TBL] [Abstract][Full Text] [Related]
19. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
[TBL] [Abstract][Full Text] [Related]
20. Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis.
Warr D; Willan A; Fine S; Wilson K; Davis A; Erlichman C; Rusthoven J; Lofters W; Osoba D; Laberge F
J Natl Cancer Inst; 1991 Aug; 83(16):1169-73. PubMed ID: 1653363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
